undefined

Tiwa Adebayo

Bloomberg reporter covering European markets and equities, providing market color and company-specific reporting on stocks affected by energy prices and geopolitical events.

Top 5 podcasts with Tiwa Adebayo

Ranked by the Snipd community
undefined
Apr 2, 2026 • 4min

BP Up, Lufthansa Down, Fresnillo Drops

Tiwa Adebayo, Bloomberg reporter on European markets and equities. She explains how a surge in oil after President Trump’s Iran comments sent stocks and bonds lower. She covers BP’s gains from higher crude. She discusses airlines, including Lufthansa, facing fuel-cost risks and why miners like Fresnillo fell amid tariff and energy uncertainty.
undefined
Apr 1, 2026 • 5min

Rolls-Royce Gains, Lufthansa Rises, Berkeley Tumbles

Tiwa Adebayo, Bloomberg reporter covering markets and companies, breaks down big movers. Rolls‑Royce jumps on defense and energy interest. Airlines navigate Middle East risks and contingency planning. UK housebuilder Berkeley tumbles after sharply cut profit outlook tied to regional uncertainty.
undefined
Mar 30, 2026 • 5min

Rio Tinto Jumps, Sodexo Gains, BFF Bank Slumps

Tiwa Adebayo, Bloomberg markets reporter known for clear European stock analysis. She explains Rio Tinto’s rally linked to Middle East strikes and shipping resumption. She covers Sodexo’s boost after a Jefferies upgrade and leadership change. She outlines BFF Bank’s dramatic plunge after a loan-classification review and regulatory scrutiny.
undefined
Mar 30, 2026 • 4min

Rio Tinto Jumps, Sodexo Gains, Boohoo Rises

Tiwa Adebayo, Bloomberg reporter covering European markets and corporate news. She breaks down how Iran's strikes pushed aluminium prices and lifted mining stocks. She covers Sodexo's upgrade, upcoming results and leadership change. She highlights Boohoo beating FY26 guidance and signs of a successful turnaround.
undefined
Mar 27, 2026 • 4min

Enagas Soars, AstraZeneca Gains, Pernod Ricard Rises

Tiwa Adebayo, Bloomberg equities reporter who covers European markets on the ground. She breaks down Enagas's surge after a regulator's draft proposal. She covers AstraZeneca’s COPD trial news and its market implications. She discusses Pernod Ricard’s reported talks about Brown‑Forman and potential U.S. market impact.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app